therapeutic 1,724 words KG: astrocyte
Contents

Astrocyte Metabolic Modulation Therapy for Neurodegeneration

💊 Therapeutic Info
Nameastrocyte
Key Genes/ProteinsABCA1, AGER, ALDH1L1, APOE, AQP4, BDNF
Related DiseasesAlzheimer's disease
Linked Hypotheses31 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (181)

Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.67
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A
Score: 0.67
Oligodendrocyte White Matter Vulnerability
Score: 0.65
Programmable Neuronal Circuit Repair via Epigenetic CRISPR
Score: 0.63
Cholesterol-CRISPR Convergence Therapy for Neurodegeneration
Score: 0.62
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
Epigenetic Memory Reprogramming for Alzheimer's Disease
Score: 0.61
Glycosaminoglycan Template Disruption Approach
Score: 0.60
Brain Insulin Resistance with Glucose Transporter Dysfunctio
Score: 0.60
Extracellular Vesicle Biogenesis Modulation
Score: 0.58
Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy
Score: 0.55
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.54
PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor
Score: 0.53
Synthetic Biology Approach: Designer Mitochondrial Export Sy
Score: 0.51
Microglia-Derived Extracellular Vesicle Engineering for Targ
Score: 0.48
Optogenetic Control of Mitochondrial Transfer Networks
Score: 0.48
Gap Junction Hemichannel Modulation for Controlled Mitochond
Score: 0.36
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.74
The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.65
Liquid-Liquid Phase Separation Modifier Therapy
Score: 0.55
← Prevpg 9/10Next →

Related Analyses (30)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · completed
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40
Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40
Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.40
Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · completed · Score: 0.40

See Also (15)

Neuroimaging for Parkinsonian Syndromes (NCT03872102)
clinical · Pages share 27 hypotheses
Beta-Propeller Protein-Associated Neurodegeneration (BP
disease · Pages share 139 hypotheses
Synaptic Biomarkers in Neurodegeneration
biomarker · Pages share 139 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 139 hypotheses
Olfactory Mucosa, Blood and Urine for Identification of
clinical · Pages share 139 hypotheses

Knowledge Graph (12 edges)

MAP1LC3B expressed_in astrocyte
CB2R expressed_in astrocyte
APOE regulates astrocyte
astrocyte associated_with Multiple sclerosis
NRF2 expressed_in astrocyte
BMAL1 expressed_in astrocyte
NOX4 expressed_in astrocyte
STAT3 regulates astrocyte
reactive_astrocyte associated_with astrocyte
C3 expressed_in astrocyte

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.